Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus: Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Cardiovascular disease is the leading cause of mortality in type 1 diabetes mellitus (T1DM) and relates strongly to insulin resistance (IR). Lean and obese adolescents with T1DM have marked IR. Metformin improves surrogate markers of IR in T1DM, but its effect on directly measured IR and vascular health in youth with T1DM is unclear. We hypothesized that adolescents with T1DM have impaired vascular function and that metformin improves this IR and vascular dysfunction. Methods: Adolescents with T1DM and control participants underwent magnetic resonance imaging of the ascending (AA) and descending aorta to assess pulse wave velocity, relative area change, and maximal (WSS MAX ) and time-averaged (WSS TA ) wall shear stress. Participants with T1DM also underwent assessment of carotid intima-media thickness by ultrasound, brachial distensibility by DynaPulse, fat and lean mass by dual-energy x-ray absorptiometry, fasting laboratories after overnight glycemic control, and insulin sensitivity by hyperinsulinemic-euglycemic clamp (glucose infusion rate/insulin). Adolescents with T1DM were randomized 1:1 to 3 months of 2000 mg metformin or placebo daily, after which baseline measures were repeated. Results: Forty-eight adolescents with T1DM who were 12 to 21 years of age (40% body mass index [BMI] ≥90th percentile; 56% female) and 24 nondiabetic control participants of similar age, BMI, and sex distribution were enrolled. Adolescents with T1DM demonstrated impaired aortic health compared with control participants, including elevated AA and descending aorta pulse wave velocity, reduced AA and descending aorta relative area change, and elevated AA and descending aorta WSS MAX and WSS TA . Adolescents with T1DM in the metformin versus placebo group had improved glucose infusion rate/insulin (12.2±3.2 [mg·kg −1 ·min −1 ]/μIU/μL versus −2.4±3.6 [mg·kg −1 ·min −1 ]/μIU/μL, P =0.005; 18.6±4.8 [mg·lean kg −1 ·min −1 ]/μIU/μL versus −3.4±5.6 [mg·lean kg −1 ·min −1 ]/μIU/μL, P =0.005) and reduced weight (−0.5±0.5 kg versus 1.6±0.5 kg; P =0.004), BMI (−0.2±0.15 kg/m 2 versus 0.4±0.15 kg/m 2 ; P =0.005), and fat mass (−0.7±0.3 kg versus 0.6±0.4 kg; P =0.01). Glucose infusion rate/insulin also improved in normal-weight participants (11.8±4.4 [mg·kg −1 ·min −1 ]/μIU/μL versus −4.5±4.4 [mg·kg −1 ·min −1 ]/μIU/μL, P =0.02; 17.6±6.7 [mg·lean kg −1 ·min −1 ]/μIU/μL versus −7.0±6.7 [mg·lean kg −1 ·min −1 ]/μIU/μL, P =0.02). The metformin group had reduced AA WSS MAX (−0.3±0.4 dyne/cm 2 versus 1.5±0.5 dyne/cm 2 ; P =0.03), AA pulse wave velocity (−1.1±1.20 m/s versus 4.1±1.6 m/s; P =0.04), and far-wall diastolic carotid intima-media thickness (−0.04±0.01 mm versus −0.00±0.01 mm; P =0.049) versus placebo. Conclusions: Adolescents with T1DM demonstrate IR and impaired vascular health compared with control participants. Metformin improves IR, regardless of baseline BMI, and BMI, weight, fat mass, insulin dose, and aortic and carotid health in adolescents with T1DM. Metformin may hold promise as a cardioprotective intervention in T1DM. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01808690.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Flow-mediated endothelial mechanotransduction
Davies, P. F. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.519 · Cited by 2,802
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287
Can clinical factors estimate insulin resistance in type 1 diabetes?
Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.626 · Cited by 640
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492
Griffin, S. J., Leaver, J. K., & Irving, G. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4337-9 · Cited by 398
Petrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30194-8 · Cited by 357
Libby, P., Nathan, D. M., Abraham, K., Brunzell, J. D., Fradkin, J. E., Haffner, S. M., Hsueh, W., Rewers, M., Roberts, B. T., Savage, P. J., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.529651 · Cited by 265
Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M. (2011) · Diabetes · doi:10.2337/db10-0328 · Cited by 230
Nesti, L., & Natali, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.009 · Cited by 211
Cited by
Biological Versus Chronological Aging
Hamczyk, M. R., Nevado, R. M., Barettino, A., Fuster, V., & Andrés, V. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.062 · Cited by 489
Han, Y.-C., Tang, S.-Q., Liu, Y.-T., Li, A.-M., Zhan, M., Yang, M., Song, N., Zhang, W., Wu, X.-Q., Peng, C.-H., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04184-8 · Cited by 257
Herman, R., Kravos, N. A., Jensterle, M., Janež, A., & Dolžan, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031264 · Cited by 254
Ayoub, R., Ruddy, R. M., Cox, E., Oyefiade, A., Derkach, D., Laughlin, S., Ades-aron, B., Shirzadi, Z., Fieremans, E., MacIntosh, B. J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0985-2 · Cited by 117
Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
Cree-Green, M., Bergman, B. C., Cengiz, E., Fox, L. A., Hannon, T. S., Miller, K., Nathan, B., Pyle, L., Kahn, D., Tansey, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00129 · Cited by 101
Self-citation
Metadata
- Authors
- Bjornstad, P., Schäfer, M., Truong, U., Cree-Green, M., Pyle, L., Baumgartner, A., Garcia Reyes, Y., Maniatis, A., Nayak, S., Wadwa, R. P., Browne, L. P., Reusch, J. E. B., & Nadeau, K. J.
- Venue
- Circulation
- Published
- 2018-12-18
- Volume
- 138
- Issue
- 25
- Pages
- 2895-2907
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2907961170
- Cited by
- 143
- References
- 12
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus: Randomized Controlled Trial. https://app.cochat.ai/papers/10.1161/circulationaha.118.035525
- The paper
- Bjornstad, P., Schäfer, M., Truong, U., Cree-Green, M., Pyle, L., Baumgartner, A., Garcia Reyes, Y., Maniatis, A., Nayak, S., Wadwa, R. P., Browne, L. P., Reusch, J. E. B., & Nadeau, K. J. (2018). Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus: Randomized Controlled Trial. Circulation. https://doi.org/10.1161/circulationaha.118.035525
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.